Pharma Industry News

A ‘nightmare bacteria’ is surging while investment in antibiotics lags

Experts are sounding the alarm about the rise in drug-resistant superbugs and urging more action.

Experts are sounding the alarm about the rise in drug-resistant superbugs and urging more action.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]